A diabetic mouse model of gas gangrene
INTRODUCTION: Since Clostridium perfringens gas gangrene is strongly associated with human diabetes, this study compared gas gangrene severity in db/db (a model for type 2 diabetes) vs wild-type (WT) mice after a 4 h C. perfringens challenge. MATERIAL AND METHODS: washed cells of C. perfringens type A strain ATCC3624 and ii) the right hind thigh with DPBS. After 4 h, mice were euthanized and samples of muscle and subcutaneous tissue from those thighs were collected for anaerobic culture or histology examination. RESULTS: bacterial challenges, the db/db mice showed more severe gross and microscopic lesions than did WT mice. No gross or microscopic lesions were observed in the right thigh of any mice. No significant differences were noted in C. perfringens numbers recovered from the left thigh of db/db vs WT mice at any challenge inoculum. After a 2 h challenge, RT-qPCR detected more expression of genes encoding alpha toxin and perfringolysin O in the db/db than in WT mice. DISCUSSION: This study supports the usefulness of db/db mice to study C. perfringens gas gangrene pathogenesis in diabetics. It also suggests that higher BCAA and glucose levels and/or stronger upregulation of toxin production in db/db mice may be factors that help cause the development of more severe lesions during the early stages of gas gangrene in the db/db mice.
Authors
- Juliann Beingesser
- Mauricio A. Navarro (ORCID: https://orcid.org/0000-0002-7744-8052)
- Bruce A. McClane (ORCID: https://orcid.org/0000-0003-2451-5140)
- Francisco A. Uzal (ORCID: https://orcid.org/0000-0003-0681-1878)
- Jihong Li
- Jessica Banuelos
Institutions
- California Department of Food and Agriculture (US)
- University of Pittsburgh (US)
- California State University, San Bernardino (US)
Publication Details
- Journal
- Anaerobe
- Published
- 2026-05-01
- DOI
- https://doi.org/10.1016/j.anaerobe.2026.103050
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute of Allergy and Infectious Diseases